TLX 1.83% $17.80 telix pharmaceuticals limited

Ann: Telix Announces A$600 Million Convertible Bonds Offering, page-34

  1. 68 Posts.
    lightbulb Created with Sketch. 58
    Fund managers were being offered $US150 million ($226 million) worth of shares in cancer treatment hopeful Telix Pharmaceuticals after Tuesday’s close, as JPMorgan got going on the delta placement leg of a $600 million convertible notes deal in lieu of an abandoned Nasdaq listing.

    Terms sent to potential investors show Telix shares were being offered under a variable price book build at $18.60 a share to $19.60. That represented a 3.5 per cent to 8.4 per cent discount to the last close. The book was due to shut at 7:30pm.

    Source - Australian Financial Review
    Last edited by nathan1984: 24/07/24
 
watchlist Created with Sketch. Add TLX (ASX) to my watchlist
(20min delay)
Last
$17.80
Change
0.320(1.83%)
Mkt cap ! $5.956B
Open High Low Value Volume
$17.83 $17.88 $17.43 $15.18M 856.7K

Buyers (Bids)

No. Vol. Price($)
1 2418 $17.79
 

Sellers (Offers)

Price($) Vol. No.
$17.80 18320 1
View Market Depth
Last trade - 16.10pm 09/08/2024 (20 minute delay) ?
TLX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.